kynostatin 272 has been researched along with saquinavir in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, B; Erickson, JW; Gulnik, SV; Liu, B; Mitsuya, H; Suvorov, LI; Yu, B | 1 |
| Hirono, S; Kato, R; Kiso, Y; Moriguchi, I; Takahashi, O | 1 |
| Davis, DA; Fukazawa, T; Hayashi, H; Höglund, S; Humphrey, RW; Mitsuya, H; Ohagen, A; Yarchoan, R | 1 |
| Maeda, Y; Mitsuya, H; Uchida, H | 1 |
| Aquaro, S; Caliò, R; Davis, DA; Humphrey, RW; Newcomb, FM; Perno, CF; Yarchoan, R | 1 |
| Burt, SK; Erickson, JW; Rick, SW; Topol, IA | 1 |
| Gold, D; Loftus, R | 1 |
7 other study(ies) available for kynostatin 272 and saquinavir
| Article | Year |
|---|---|
Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.
Topics: Amino Acid Sequence; Binding Sites; Carbamates; Cloning, Molecular; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; HIV-1; Indinavir; Isoquinolines; Kinetics; Methylurea Compounds; Mutagenesis, Site-Directed; Oligopeptides; Point Mutation; Pyridines; Quinolines; Recombinant Proteins; Saquinavir; Structure-Activity Relationship; Thiazoles; Valine | 1995 |
Solution structure of HIV-1 protease-allophenylnorstatine derivative inhibitor complex obtained from molecular dynamics simulation.
Topics: HIV Protease Inhibitors; Humans; Isoquinolines; Models, Chemical; Oligopeptides; Quinolines; Saquinavir; Solutions | 1994 |
Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.
Topics: Blotting, Western; Cells, Cultured; Chromatography, High Pressure Liquid; Fusion Proteins, gag-pol; HIV Protease Inhibitors; HIV-1; Oligopeptides; Polymerase Chain Reaction; Saquinavir; Virion | 1997 |
HIV-1 protease does not play a critical role in the early stages of HIV-1 infection.
Topics: Chloramphenicol O-Acetyltransferase; HeLa Cells; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Oligopeptides; Ritonavir; Saquinavir | 1997 |
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
Topics: Anti-HIV Agents; Cell Line; Cells, Cultured; HIV Core Protein p24; HIV Protease Inhibitors; HIV-1; Humans; Macrophages; Monocytes; Oligopeptides; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine | 1998 |
Molecular mechanisms of resistance: free energy calculations of mutation effects on inhibitor binding to HIV-1 protease.
Topics: Computer Simulation; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Kinetics; Models, Chemical; Models, Molecular; Molecular Conformation; Mutation; Oligopeptides; Saquinavir | 1998 |
Protease inhibitors: where are they now?
Topics: Animals; Blood Proteins; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Industry; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Oligopeptides; Protein Binding; Pyrones; Quinolines; Rats; Saquinavir; Technology, Pharmaceutical; Urea; Warfarin; Zidovudine | 1995 |